353 related articles for article (PubMed ID: 22651914)
1. Structural studies of the TGF-βs and their receptors - insights into evolution of the TGF-β superfamily.
Hinck AP
FEBS Lett; 2012 Jul; 586(14):1860-70. PubMed ID: 22651914
[TBL] [Abstract][Full Text] [Related]
2. Silencing of TGF-beta signalling by the pseudoreceptor BAMBI.
Onichtchouk D; Chen YG; Dosch R; Gawantka V; Delius H; Massagué J; Niehrs C
Nature; 1999 Sep; 401(6752):480-5. PubMed ID: 10519551
[TBL] [Abstract][Full Text] [Related]
3. A silent H-bond can be mutationally activated for high-affinity interaction of BMP-2 and activin type IIB receptor.
Weber D; Kotzsch A; Nickel J; Harth S; Seher A; Mueller U; Sebald W; Mueller TD
BMC Struct Biol; 2007 Feb; 7():6. PubMed ID: 17295905
[TBL] [Abstract][Full Text] [Related]
4. TGF-β family co-receptor function and signaling.
Nickel J; Ten Dijke P; Mueller TD
Acta Biochim Biophys Sin (Shanghai); 2018 Jan; 50(1):12-36. PubMed ID: 29293886
[TBL] [Abstract][Full Text] [Related]
5. A molecular recognition paradigm: promiscuity associated with the ligand-receptor interactions of the activin members of the TGF-beta superfamily.
Keah HH; Hearn MT
J Mol Recognit; 2005; 18(5):385-403. PubMed ID: 15948132
[TBL] [Abstract][Full Text] [Related]
6. Localization of Smads, the TGF-beta family intracellular signaling components during endochondral ossification.
Sakou T; Onishi T; Yamamoto T; Nagamine T; Sampath Tk; Ten Dijke P
J Bone Miner Res; 1999 Jul; 14(7):1145-52. PubMed ID: 10404014
[TBL] [Abstract][Full Text] [Related]
7. Structural and functional evidence for a singular repertoire of BMP receptor signal transducing proteins in the lophotrochozoan Crassostrea gigas suggests a shared ancestral BMP/activin pathway.
Herpin A; Lelong C; Becker T; Rosa F; Favrel P; Cunningham C
FEBS J; 2005 Jul; 272(13):3424-40. PubMed ID: 15978047
[TBL] [Abstract][Full Text] [Related]
8. Divergence and convergence of TGF-beta/BMP signaling.
Miyazono K; Kusanagi K; Inoue H
J Cell Physiol; 2001 Jun; 187(3):265-76. PubMed ID: 11319750
[TBL] [Abstract][Full Text] [Related]
9. The role of bone morphogenetic proteins in ovarian function.
Shimasaki S; Moore RK; Erickson GF; Otsuka F
Reprod Suppl; 2003; 61():323-37. PubMed ID: 14635945
[TBL] [Abstract][Full Text] [Related]
10. Crystal structure of the BMP-2-BRIA ectodomain complex.
Kirsch T; Sebald W; Dreyer MK
Nat Struct Biol; 2000 Jun; 7(6):492-6. PubMed ID: 10881198
[TBL] [Abstract][Full Text] [Related]
11. Activins and inhibins and their signaling.
Vale W; Wiater E; Gray P; Harrison C; Bilezikjian L; Choe S
Ann N Y Acad Sci; 2004 Dec; 1038():142-7. PubMed ID: 15838109
[TBL] [Abstract][Full Text] [Related]
12. The novel type I serine-threonine kinase receptor Alk8 binds TGF-beta in the presence of TGF-betaRII.
de Caestecker MP; Bottomley M; Bhattacharyya S; Payne TL; Roberts AB; Yelick PC
Biochem Biophys Res Commun; 2002 May; 293(5):1556-65. PubMed ID: 12054694
[TBL] [Abstract][Full Text] [Related]
13. Promiscuity and specificity in BMP receptor activation.
Mueller TD; Nickel J
FEBS Lett; 2012 Jul; 586(14):1846-59. PubMed ID: 22710174
[TBL] [Abstract][Full Text] [Related]
14. A road map toward defining the role of Smad signaling in hematopoietic stem cells.
Utsugisawa T; Moody JL; Aspling M; Nilsson E; Carlsson L; Karlsson S
Stem Cells; 2006 Apr; 24(4):1128-36. PubMed ID: 16357343
[TBL] [Abstract][Full Text] [Related]
15. Cell-type specific regulation of myostatin signaling.
Kemaladewi DU; de Gorter DJ; Aartsma-Rus A; van Ommen GJ; ten Dijke P; 't Hoen PA; Hoogaars WM
FASEB J; 2012 Apr; 26(4):1462-72. PubMed ID: 22202673
[TBL] [Abstract][Full Text] [Related]
16. Molecular characterization of a type I serine-threonine kinase receptor for TGF-beta and activin in the rat pituitary tumor cell line GH3.
Takumi T; Moustakas A; Lin HY; Lodish HF
Exp Cell Res; 1995 Jan; 216(1):208-14. PubMed ID: 7813622
[TBL] [Abstract][Full Text] [Related]
17. Cooperative assembly of TGF-beta superfamily signaling complexes is mediated by two disparate mechanisms and distinct modes of receptor binding.
Groppe J; Hinck CS; Samavarchi-Tehrani P; Zubieta C; Schuermann JP; Taylor AB; Schwarz PM; Wrana JL; Hinck AP
Mol Cell; 2008 Feb; 29(2):157-68. PubMed ID: 18243111
[TBL] [Abstract][Full Text] [Related]
18. Lack of transforming growth factor-beta type II receptor expression in human retinoblastoma cells.
Horie K; Yamashita H; Mogi A; Takenoshita S; Miyazono K
J Cell Physiol; 1998 Jun; 175(3):305-13. PubMed ID: 9572475
[TBL] [Abstract][Full Text] [Related]
19. Genomic analyses facilitate identification of receptors and signalling pathways for growth differentiation factor 9 and related orphan bone morphogenetic protein/growth differentiation factor ligands.
Mazerbourg S; Hsueh AJ
Hum Reprod Update; 2006; 12(4):373-83. PubMed ID: 16603567
[TBL] [Abstract][Full Text] [Related]
20. The structure of the follistatin:activin complex reveals antagonism of both type I and type II receptor binding.
Thompson TB; Lerch TF; Cook RW; Woodruff TK; Jardetzky TS
Dev Cell; 2005 Oct; 9(4):535-43. PubMed ID: 16198295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]